SlideShare a Scribd company logo
1 of 121
Dr. Saumya, Dept of Pathology, SIMS
www.shadan.in
NORMAL OVARIES
 Normal size 5 x 3 x 3cm
 Variation in dimensions can result from
 Endogenous hormonal production(varies with age and
menstrual cycle)
 Exogenous substances, including OCs, GnRH agonists, or
ovulation-inducing medication, may affect size
Lifetime Risk of ovarian neoplasm
 A woman has 5–10% lifetime risk of undergoing surgery
for a suspected ovarian neoplasm and
 13–21% of these will be found to be have an ovarian
malignancy
 Differential diagnosis of the adnexal masses varies considerably with
the age of the patients.
 In pre-menarchal girls and post-menopausal women adnexal mass
should be considered highly abnormal – requires immediate
investigation.
 In menstruating patients differential diagnosis is varied.
Clinical features:
1. Pelvic pain
2. Menstrual irregularities ( abnormal pattern of
ovarian hormone secretion).
3. Infertility; failure of ovulation (Stein-Leventhal).
4. Ovarian mass : either non-neoplastic (cysts) or
neoplastic (cystic or solid).
DIAGNOSTIC EVALUATION OF THE PATIENT WITH AN
ADNEXAL MASS
 Complete physical examination
 Pelvic ultrasound examination
 Computed tomography scan with contrast enhancement or
intravenous pyelography
 Colonoscopy or barium enema study, if symptomatic
 Laparoscopy, laparotomy
OVARIAN
MASSES
FUNCTIONAL INFLAMMATORY NEOPLASTIC OTHERS
FOLLICULAR CYST
CORPUS LUTEUM
CYST
THECA LUTEIN
TUBO OVARIAN ABSCESS BENIGN
BORDERLINE
MALIGNANT
ENDOMETRIOMA
ENLARGED PCO
PAROVARIAN CYST
COMMON OVARIAN TUMOURS
Infancy Pre pubertal Adolescent Reproductive Peri
Menopausal
Post
Menopausal
1 Functional
cyst
Functional
cyst
Functional
cyst
Functional
cyst
Epithelial
ovarian
tumor
Neoplastic
ovarian
tumor
2. Germ cell
tumor
Germ cell
tumor
Germ cell
tumor
Dermoid Functional
cyst
Functional
cyst
3. Epithelial
tumor
Epithelial
tumor
Mets
Functional ovarian cysts
 Follicular cysts
 Corpus luteum cysts
 Theca lutein cysts
 Luteomas of pregnancy
By far the most common clinically detectable enlargements
of the ovary in the reproductive years.
All are benign and usually asymptomatic.
Follicular cysts
 Cystic follicle is defined as Follicular cyst of diameter > 3cm
 Most common functional cysts.
 Rarely larger than 8cm.
 Lined by granulosa cells
 Found incidentally on pelvic examination
 Usually resolve within 4 – 8 weeks with expectant management
 May rupture or torse occasionally causing pain and peritoneal
symptoms.
Follicular cysts
Corpus luteal cyst
 Less common than follicular cyst.
 May rupture leading to hemoperitoneum and requiring surgical
management( more in patients taking anti coagulants or with
bleeding diathesis)
 Unruptured cysts may cause pain because of bleeding into
enclosed ovarian cyst cavity.
Corpus luteal cyst
Theca lutein cysts
 Least common
 Usually bilateral
 Result from overstimulation of the ovary by β- hCG
 Do not commonly occur in normal pregnancy
 Often associated with hydatidiform moles, choriocarcinoma,
multiple gestations, use of clomiphene and GnRH analogues.
 May be quite large (up to 30 cm) , multicystic, and regress
spontaneously.
Theca lutein cysts
Polycystic ovarian (Stein-Leventhal
syndrome(PCOD)
 It is important cause of infertility. There is excessive
production of androgens, increase conversion of androgens to
estrogen, insulin resistance, and inappropriate gonadotrophin
production by the pituitary.
 Morphology: Ovaries are large, white, many subcortical
follicular cysts(0.5-1 cm.) in diameter, and covered by
thickened fibrosed outer tunica. No corpora lutea (= no
ovulation).
 Manifestations: Young females with Oligomenorrhea,
infertility, obesity & hirsuitism.
Polycystic ovary
Endometriosis (chocolate cyst)
 Most common site of involvement is the ovary.
 Endometriomas are pseudocysts formed by invagination of the ovarian
cortex, sealed off by adhesions.
 They may completely replace normal ovarian tissue. Cyst walls are usually
thick and fibrotic.
 USG: anechoic cysts to cysts with diffuse low-level echoes to solid-
appearing masses.
Fluid–fluid or debris–fluid levels may also be seen.
They may be unilocular or multilocular with thin or thick septations
 Malignant transformation: 0.3% to 0.8%
 Management: medical and/ or surgical
Management of functional cysts
 Expectant
 Watchful waiting for two or three cycles is appropriate.
 Combined oral contraceptives appear to be of no benefit.
 Should cysts persist, surgical management is often
indicated.
Oral contraceptives for functional ovarian cysts (Review)
Cochrane Database of Systematic Reviews 2011
OVARIAN TUMORS
- Common forms of neoplasia in women.
- 80-90% of ovarian tumors are benign.
- Most ovarian tumors occur between 20-45 years.
- Ovarian cancer is second MC malignancy of the female
genital tract (after endometrial cancer).
- Most ovarian tumors are derived from surface epithelium,
and “CA-125” is the tumor marker for surface epithelial
tumors of the ovary.
- Malignant ovarian tumors present at a late stage, thus are
associated with high mortality rate.
- Known risk factors are nulliparity, family history, and
specific inherited mutations (BRCAI & BRCAII) genes.
Precursor Ovarian component Other female genital tract
structures
Coelomic epithelium
Ectopic endometrial
epithelium—Mullerian
Epithelium
Surface epithelium 1.Fallopian tubes( ciliated
columnar serous cells)
2.Endometrial lining(non
ciliated columnar cells)
3. Endocervical glands
(mucinous non ciliated)
Yolk Sac Germ cells(toti potent)
Sex cords Stroma of the ovary Endocrine apparatus of post
natal ovary.
Tumour types-- a basic classification
Site of origin Types Frequency Age group
Surface epithelial
tumours
1.Serous
2.Mucinous
3.Endometroid
4.Clear cell
5.Brenner
60%-70% 20 years and greater
Germ cell 1.Teratoma
2.Dysgerminoma
3.Endodermal Sinus(Yolk Sac
Tumour)
4.Choriocarcinoma
15%-20% 0 to 25 years and
greater
Sex cord stromal
tumours
1.Granulosa Theca cell
tumours
2.Sertoli-Leydig cell tumours
3.Gynandroblastoma
5%-10% All ages
Miscellaneous 1.Lipid cell tumour
2.Gonadoblastoma
Variable variable
Metastasis Krukenberg tumours 5% variable
III. SEX CORD-STROMAL TUMORS:
1- Granulosa-Theca cell tumor: secrete
estrogen
2- Sertoli-Leydig cell tumor: secrete androgens
3- Fibroma: associated with Meig’s syndrome
4- Sex cord stromal tumor with annual tubules
5- Gynandroblastoma
6- Steroid (Lipid)cell tumors
I. Surface mullerian epithelial tumors: (Benign,
Borderline, and Malignant)
1-Serous tumors: composed of ciliated columnar (tubal
type) epithelium
2- Mucinous tumors: composed of mucus-secreting
(cervical canal type) epithelium
3- Endometrioid tumors: composed of glandular
(endometrium-like) epithelium.
4- Brenner’s tumors: composed of transitional
(urothelium-like) epithelium
5- Clear cell tumors.
Serous tumors
Cysts are lined by tall columnar, ciliated epithelial cells (fallopian tube type)
& filled with serous fluid.
Types:
 Benign Serous Tumors (Cystadenomas): (60%),
smooth lining & no papillary or solid areas. 20% are bilateral.
 Borderline Serous Tumors (low malignant potential): (15%),
epithelial atypia, solid areas, but no stromal invasion. 30% are bilateral.
 Malignant Serous Tumors (Cystadenocarcinomas): (25%)
multilayered epithelium, solid areas & papillary structures
invasing the stroma. 65% are bilateral. The prognosis depends on
stage, and the presence of peritoneal implants means poor prognosis.
Serous cystadenomas
 Benign tumors typically have a smooth glistening cyst
wall with no epithelial thickening or with small papillary
projections.
 Microscopy : the cysts are lined by columnar epithelium,
which has abundant cilia in benign tumors. Microscopic
papillae may be found
Borderline serous tumours
 Borderline tumors contain an increased number of
papillary projections
 Exhibit increased complexity of the stromal papillae –
hierarchical pattern, stratification of the epithelium and
mild nuclear atypia, but invasion of the stroma is not seen
or there is stromal microinvasion (< 1cm).
Borderline serous tumours
Stromal
microinvasion
Serous carcinoma
 Serous carcinoma are classified into 2 subtype
 low-grade serous carcinoma (LGSC)
 High-grade serous carcinoma(HGSC)
 These tumors are different based on their molecular study.
Pathogenesis
APST - Atypical proliferative serous tumour
SBT – Serous borderline tumour
Spread of STIC from the Fimbria to the Ovarian Surface
Development of Cortical Inclusion Cyst from Tubal Epithelium
HGSC
• Most common ovarian carcinomas.
• High stage disease at the time of presentation.
• Histopathology:
– Highly stratified epithelium with a fenestrated appearance
and slit-like spaces, with/without solid or microcystic
growth.
– The tumor cells are of intermediate size, with scattered
bizarre mononuclear giant cells, prominent nucleoli, and
high mitotic rate.
– >3 fold variation in nuclear size, and mitosis >12/10HPF
distinguishes HGSC from LGSC.
LGSC
• Uncommon tumor(<5%) with excellent prognosis due
to its indolent course and delayed recurrence.
• Histopathology:
– Uniform nuclei and differentiated architecture with
papillary growth;
– Numerous psammoma bodies.
– The uniformity of the nuclei with <3 fold variation, is the
principal criterion for distinguishing between LGSC and
HGSC.
– LGSC is considered microinvasive if invasive foci measures
<10mm2.
• Molecular genetics:
– BRAF mutation
– KRAS mutation
– Unlike HGSC, no BRCA germline mutation, no
chromosomal instability.
• Therapy:
– Surgical excision.
– Unlike HGSC, it is Less sensitive for platinum based
chemotherapy.
Low grade ovarian serous
carcinoma with a micropapillary
pattern
Transition between borderline
serous cystadenoma and
invasive low grade serous
carcinoma.
Mucinous carcinoma
 Arise from transitional epithelial nests in paraovarian locations at
the tubo-peritoneal junction.
 Histopathology:
 Heterogeneous group of tumors.
 Benign-appearing, borderline, intraepithelial carcinoma, and
invasive patterns may coexist within an individual neoplasm
 Mucinous borderline tumor with intraepithelial carcinoma is
used for those tumors that lack the architectural features of
carcinoma but show cytological features of malignancy.
Large cystic masses, huge size, unilateral and multiloculated. Cysts filled with
sticky gelatinous fluid. They either lined by tall columnar mucus-secreting (rich
in glycoprotein) epithelium (intestinal-type mucinous cystomas) or show
papillary architectures and focal cilia (mullerian mucinous tumors), which may
be associated with endometriosis.
1- Benign Mucinous Tumors (cystadenomas):
80%; large cysts with smooth lining & no atypia. 5% are bilateral.
2- Borderline Mucinous Tumors (of low malignant potential):
10-15%; cellular atypia, but no stromal invasion.
3- Malignant Mucinous Tumors (Cystadenocarcinomas):
5-10%; atypia, solid sheets & stromal invasion.
20% bilateral.
Seeding in the peritoneum with malignant deposits causes
pseudomyxoma peritonei.
Usually mucinous cystadenocarcinomas are of intestinal type.
 Pseudomyxoma peritonei is marked by extensive
mucinous ascites, cystic epithelial implants on the
peritoneal surfaces, adhesions, and frequent involvement
of the ovaries.
 Pseudomyxoma peritonei, if extensive, may result in
intestinal obstruction and death
Borderline mucinous cystadenoma-ovary
Borderline mucinous cystadenoma
Mucinous cystadenocarcinoma
• 20% of all ovarian tumours.
• Majority are carcinomas, if benign forms are present they
are cyst adenofibromas.
• Distinguished from serous and mucinous tumours by
presence of tubular glands bearing close resemblance to
benign or malignant endometrial glands.
• 30% associated with carcinoma endometrium and
15% with endometriosis whereas 40% involve both
ovaries.
Endometriod carcinoma
 Gross: presence of both solid
and cystic areas
 Microscopic: Tubular
glands resemble those of
typical endometrial
adenocarcinoma.
Clear cell tumour
 These are uncommon and aggressive tumours.
 Grossly can present in solid and or cystic pattern (solid
tumour with cysts and necrosis)
 Microscopically: large epithelial cells with abundant clear
cytoplasm.
Brenner tumour
 Uncommon adenofibromas
 Epithelial components– nests of transitional cells
resembling urinary bladder.
 Most are benign,variable size(1cm to 30 cm).
 Gross—solid or cystic
 Microscopic – fibrous stroma resembling normal ovarian
stroma seperated by sharply demarcated nests of urinary
tract, with mucinous glands.
Brenner tumour
 Gross:A sharply
demarcated, yellow-white
fibromatous tumor
occupies a portion of the
sectioned surface of the
ovary.
Microscopically:Nests of
transitional cells, some
containing cysts, lie in a
fibromatous stroma.
II. GERM CELL TUMORS:
1- Teratoma
2- Dysgerminoma (seminoma ovarii)
3- Yolk sac tumor= Endodermal sinus tumor
4- Embryonal carcinoma (MC mixed with other
types)
5- Choriocarcinoma (MC mixed with other types)
Germ cell tumors
15-20% of all ovarian tumors. It arises from
totipotent germ cells capable of differentiation into the
three germ layers.
- Mostly benign cystic teratomas while Other
tumours are found principally in children
and young adults.
- Homologous to germ cell tumours in male testis.
Histogenesis
TERATOMAS
Mature
Benign
teratomas
Immature
Malignant
Monodermal
or highly
specialized
Mature (Benign) Teratoma: MC germ cell tumors of the ovary,
cystic (dermoid cysts), lined by skin & hairs, and filled with
sebaceous secretion. There may be mature cartilage, bone
(teeth) & other structures. 10-15% are bilateral. < 1%
undergo malignant transformation (MC sq.c.c.).
Immature (Malignant) Teratoma: Rare , solid, bulky, with areas
of hemorrhage and necrosis. It contains embryonic elements
of he three germ layers. Age: adolescent & young women.
Grading is based on the amount of immature
neuroepithelium. It causes wide spread extraovarian
metatases depending on the degree of the immaturity of the
including tissues.
Monodermal (Specialized )Teratomas: differentiate along the
line of single tissue. Examples:- Strauma ovarii is MC (mature
thyroid tissue) – Carcinoid tumor.
MATURE CYSTIC
GROSS: unilocular cysts with hair
and cheesy material. Thin walled
gray white wrinkled epidermis.hair,
tooth and calcification are found
within walls.
TERATOMA
MICROSCOPIC: cyst wall stratified
squamous epithelium and underlying
sebaceous,sweat glands and other
adnexa.other structures like thyroid
tissue,cartilage bone may be seen.
Dysgerminoma
The ovarian counterpart of testicular seminoma.
 Gross- Yellowish white to gray pink solid, fleshy
tumors, of children & young adults. 10% are bilateral.
 Microscopy: sheets of large cells, separated by fibrous
stroma infiltrated by small lymphocytes. Non-functional,
but may be mixed with other germ cell elements that
produce hCG
 Malignant, but radiosensitive & chemosensitive, with
relative good prognosis if treated early.
 GROSS: Small nodules to
very large size.Cut surface:
yellow white to gray pink
appearance and are soft and
fleshy.
 Microscopic:large vesicular
cells, clear cytoplasm and well
defined boundaries and centrally
placed regular nuclei.cells in
sheets or cords seperated by
scant fibrous stroma, which has
mature lymphocytes.
Endodermal Sinus Tumor ( Yolk Sac
Tumor)= Infantile embryonal carcinoma
It arises from mutlipotent embryonal carcinoma cells
differentiating towards yolk sac structures.
- Affects children & adolescents; grows rapidly & spreads
widely, but is radio- & chemosensitive.
- Histologically: it shows cystic spaces into which papillary
structures with central blood vessels, the cyst spaces and
papillary structures are lined by immature epithelium giving
glomeruloid or “Schiller-Duval” bodies; There are intracellular
and extracellular hyaline droplet (characteristic feature). Tumor
cells are positive for Alpha-fetoprotein (tumor marker).
Schiller Duval Bodies
Choriocacinoma
It is due to teratogenous development of germ cells.
Most cases exist in combination with other germ cell tumors.
- Resembles gestational choriocarcinoma, highly malignant,
spreads widely & elaborates hCG (tumor marker).
- Microscopic picture: malignat syncitiotrophoblasts &
cytotrophoblasts in a hemorrhagic stroma.
Gonadal choriocarcinomas are more resistant to chemotherapy
than Gestational choriocarcinomas.
III. SEX CORD-STROMAL TUMORS:
 1- Granulosa-Theca cell tumor: secrete
estrogen
 2- Sertoli-Leydig cell tumor: secrete androgens
 3- Fibroma: associated with Meig’s syndrome
 4- Sex cord stromal tumor with annual tubules
 5- Gynandroblastoma
 6- Steroid (Lipid)cell tumors
Granulosa - theca cell tumor
 1- 5% of all ovarian tumors, of peri & post-menopausal
women.
- Usually unilateral, solid white yellow, consisting of
theca cells & granulosa cells, arranged in “Call-Exner”
rosettes.
- Elaborated large amount of estrogen & may cause
precocious sexual development in children, endometrial
hyperplasia, cystic changes of the breast or endometrial
carcinoma (estrogen effects).
- Pure granulosa cell tumors are potentially malignant,
clinical malignancy occurs in 5-25% of cases, but they
are slowly growing & 10-years survival is above 85%.
- Pure Theca cell Tumors - THECOMA
 Gross: small partly solid,
partly cystic and mostly
unilateral.The neoplasm
composed of yellow-white
tissue with hemorrhage,
some of which is
intracystic
 Microscopically:
granulosa cell arranged in
various patterns like
micro,macro follicular,
trabecular,bands and
sheets.CALL-EXNER
BODIES characterstic
rosette like structures
having central rounded
pink mass surrounded by
granulosa
 Pure thecoma are almost always benign.
 Occur in post menopausal women.
 Oestrogen dominant tumours– endometrial disorders ,
carcinoma and cystic disease of breast.
 If androgen secreting – virilizing effects.
Thecoma
 Gross: a solid firm mass upto
10 cm in diameter.Section
shows. solid, lobulated,
yellow tissue.
 Microscopically : spindle
shaped theca cells along
with variable amount of
hyalinized collagen,
cytoplasm of these cells is
vacuolated and lipid laden.
SERTOLI-LEYDIG CELL TUMORS
(Androblastoma= Arrhenoblastoma= Hilus Cell
Tumors = Gonadoblastomas)
 Androgen producing neoplasm (rarely produce estrogen)
 Recapitulate the testicular counterpart & produce
masculinization or defemenization (Androgen) effect.
 Usually unilateral & benign.
 Gross: cut surface is solid and colour gray to golden brown.
 Microscopic picture: Tubules lined with Sertoli cells and Leydig cells
interspersed in the stroma.
Gynandroblastoma: Extremely rare. It consists of a mixture of granulosa/theca
& sertoli/ leydig cells. It may be benign or malignant.
Sertoli Leydig Cell Tumor-Ovary
 Common ovarian tumours. Usually bilateral
 Hormonally inactive
 Meig’s syndrome: fibroma with pleural effusion and
benign ascites.
 Gross large firm fibrous usually bi-lateral mass.
 Microscopic composed of spindle shaped well
differentiated fibroblasts and collagen.
 Fibrothecoma: combination of fibroma and thecoma.
Fibroma
Krukenberg tumor
Metastatic tumors
• Very common,
• The primary tumors is from abdominal and breast
tumors.
 A bilateral metastatic ovarian carcinoma, composed of mucin-
producing signet ring cells, metastasizing from GIT, mostly
from the stomach, it may produce pseudomyxoma peritonei
like well differentiated appendicial tumors.
Ovaries and Ovarian Tumours
Ovaries and Ovarian Tumours
Ovaries and Ovarian Tumours

More Related Content

What's hot

FIGO staging of endometrial cancer 2023.ppt
FIGO staging of endometrial cancer 2023.pptFIGO staging of endometrial cancer 2023.ppt
FIGO staging of endometrial cancer 2023.pptDr Seena Tresa Samuel
 
Pathology, Ovarian Cyst and Tumors Dr. Sufia Husain 2018
Pathology, Ovarian Cyst and Tumors Dr. Sufia Husain 2018Pathology, Ovarian Cyst and Tumors Dr. Sufia Husain 2018
Pathology, Ovarian Cyst and Tumors Dr. Sufia Husain 2018Sufia Husain
 
Carcinoma Vulva
Carcinoma VulvaCarcinoma Vulva
Carcinoma Vulvadrmcbansal
 
Endometrial carcinoma.lecture by Associate Professor Dr Aisha Elbareg
Endometrial carcinoma.lecture by Associate Professor Dr Aisha ElbaregEndometrial carcinoma.lecture by Associate Professor Dr Aisha Elbareg
Endometrial carcinoma.lecture by Associate Professor Dr Aisha ElbaregDr. Aisha M Elbareg
 
Molecular classification of endometrial cancer
Molecular classification of endometrial cancerMolecular classification of endometrial cancer
Molecular classification of endometrial cancerMohammed Nassar
 
Benign tumors of the ovary [autosaved]
Benign tumors of the ovary [autosaved]Benign tumors of the ovary [autosaved]
Benign tumors of the ovary [autosaved]hood ibanda
 
Cevical intraepithelial neoplasia & screening ppt
Cevical intraepithelial neoplasia & screening  pptCevical intraepithelial neoplasia & screening  ppt
Cevical intraepithelial neoplasia & screening pptDr H.K. Cheema
 
Endometrial cancer JNMCH AMU ALIGARH
Endometrial cancer JNMCH AMU ALIGARHEndometrial cancer JNMCH AMU ALIGARH
Endometrial cancer JNMCH AMU ALIGARHNeha Jain
 
High Grade Serous Ovarian Cancer
High Grade Serous Ovarian CancerHigh Grade Serous Ovarian Cancer
High Grade Serous Ovarian CancerJibran Mohsin
 
FIGO staging: ovarian, fallopian and peritoneal cancers. 2014
FIGO staging: ovarian, fallopian and peritoneal cancers. 2014FIGO staging: ovarian, fallopian and peritoneal cancers. 2014
FIGO staging: ovarian, fallopian and peritoneal cancers. 2014Dr Anusha Rao P
 
Ovarian carcinoma by Dr wasif ullah
Ovarian carcinoma by Dr wasif ullahOvarian carcinoma by Dr wasif ullah
Ovarian carcinoma by Dr wasif ullahAyub Medical College
 
Diagnostic challenges in uterine mesenchymal tumors
Diagnostic challenges in uterine mesenchymal tumorsDiagnostic challenges in uterine mesenchymal tumors
Diagnostic challenges in uterine mesenchymal tumorsMuneerah Saeed
 
Ovarian tumors by mahmoud kareem
Ovarian tumors by mahmoud kareemOvarian tumors by mahmoud kareem
Ovarian tumors by mahmoud kareemmahmoud kareem
 
gynaecology.Ovarian tumours.(dr.salama)
gynaecology.Ovarian tumours.(dr.salama)gynaecology.Ovarian tumours.(dr.salama)
gynaecology.Ovarian tumours.(dr.salama)student
 
Cervical intraepithelial neoplasia
Cervical intraepithelial neoplasiaCervical intraepithelial neoplasia
Cervical intraepithelial neoplasiadrmcbansal
 
Cervical intraepithelial neoplasia, carcinoma of cervix
Cervical intraepithelial neoplasia, carcinoma of cervixCervical intraepithelial neoplasia, carcinoma of cervix
Cervical intraepithelial neoplasia, carcinoma of cervixShravan Siddula
 

What's hot (20)

FIGO staging of endometrial cancer 2023.ppt
FIGO staging of endometrial cancer 2023.pptFIGO staging of endometrial cancer 2023.ppt
FIGO staging of endometrial cancer 2023.ppt
 
Pathology, Ovarian Cyst and Tumors Dr. Sufia Husain 2018
Pathology, Ovarian Cyst and Tumors Dr. Sufia Husain 2018Pathology, Ovarian Cyst and Tumors Dr. Sufia Husain 2018
Pathology, Ovarian Cyst and Tumors Dr. Sufia Husain 2018
 
Carcinoma Vulva
Carcinoma VulvaCarcinoma Vulva
Carcinoma Vulva
 
GERM CELL TUMORS OF OVARY PPT.pptx
GERM CELL TUMORS OF OVARY PPT.pptxGERM CELL TUMORS OF OVARY PPT.pptx
GERM CELL TUMORS OF OVARY PPT.pptx
 
Endometrial carcinoma.lecture by Associate Professor Dr Aisha Elbareg
Endometrial carcinoma.lecture by Associate Professor Dr Aisha ElbaregEndometrial carcinoma.lecture by Associate Professor Dr Aisha Elbareg
Endometrial carcinoma.lecture by Associate Professor Dr Aisha Elbareg
 
Molecular classification of endometrial cancer
Molecular classification of endometrial cancerMolecular classification of endometrial cancer
Molecular classification of endometrial cancer
 
Benign ovarian tumors
Benign ovarian tumorsBenign ovarian tumors
Benign ovarian tumors
 
Benign tumors of the ovary [autosaved]
Benign tumors of the ovary [autosaved]Benign tumors of the ovary [autosaved]
Benign tumors of the ovary [autosaved]
 
Cevical intraepithelial neoplasia & screening ppt
Cevical intraepithelial neoplasia & screening  pptCevical intraepithelial neoplasia & screening  ppt
Cevical intraepithelial neoplasia & screening ppt
 
Endometrial cancer JNMCH AMU ALIGARH
Endometrial cancer JNMCH AMU ALIGARHEndometrial cancer JNMCH AMU ALIGARH
Endometrial cancer JNMCH AMU ALIGARH
 
Adnexal Masses
Adnexal MassesAdnexal Masses
Adnexal Masses
 
Endometrial Carcinoma
Endometrial CarcinomaEndometrial Carcinoma
Endometrial Carcinoma
 
High Grade Serous Ovarian Cancer
High Grade Serous Ovarian CancerHigh Grade Serous Ovarian Cancer
High Grade Serous Ovarian Cancer
 
FIGO staging: ovarian, fallopian and peritoneal cancers. 2014
FIGO staging: ovarian, fallopian and peritoneal cancers. 2014FIGO staging: ovarian, fallopian and peritoneal cancers. 2014
FIGO staging: ovarian, fallopian and peritoneal cancers. 2014
 
Ovarian carcinoma by Dr wasif ullah
Ovarian carcinoma by Dr wasif ullahOvarian carcinoma by Dr wasif ullah
Ovarian carcinoma by Dr wasif ullah
 
Diagnostic challenges in uterine mesenchymal tumors
Diagnostic challenges in uterine mesenchymal tumorsDiagnostic challenges in uterine mesenchymal tumors
Diagnostic challenges in uterine mesenchymal tumors
 
Ovarian tumors by mahmoud kareem
Ovarian tumors by mahmoud kareemOvarian tumors by mahmoud kareem
Ovarian tumors by mahmoud kareem
 
gynaecology.Ovarian tumours.(dr.salama)
gynaecology.Ovarian tumours.(dr.salama)gynaecology.Ovarian tumours.(dr.salama)
gynaecology.Ovarian tumours.(dr.salama)
 
Cervical intraepithelial neoplasia
Cervical intraepithelial neoplasiaCervical intraepithelial neoplasia
Cervical intraepithelial neoplasia
 
Cervical intraepithelial neoplasia, carcinoma of cervix
Cervical intraepithelial neoplasia, carcinoma of cervixCervical intraepithelial neoplasia, carcinoma of cervix
Cervical intraepithelial neoplasia, carcinoma of cervix
 

Similar to Ovaries and Ovarian Tumours

benignovariantumours-121018102005-phpapp02.pdf
benignovariantumours-121018102005-phpapp02.pdfbenignovariantumours-121018102005-phpapp02.pdf
benignovariantumours-121018102005-phpapp02.pdfsamooo67890
 
Benign ovarian masses
Benign ovarian masses Benign ovarian masses
Benign ovarian masses Ayesha Safi
 
Benign ovarian Neoplasms Dr.H.K.Cheema-Professor-OBG.PIMS,Jalandhar
Benign ovarian Neoplasms   Dr.H.K.Cheema-Professor-OBG.PIMS,JalandharBenign ovarian Neoplasms   Dr.H.K.Cheema-Professor-OBG.PIMS,Jalandhar
Benign ovarian Neoplasms Dr.H.K.Cheema-Professor-OBG.PIMS,JalandharDr H.K. Cheema
 
Ovarian Malignant PPT.pptx
Ovarian Malignant PPT.pptxOvarian Malignant PPT.pptx
Ovarian Malignant PPT.pptxssuser17701d
 
Benign lesions of the ovaries.pptx
Benign lesions of the ovaries.pptxBenign lesions of the ovaries.pptx
Benign lesions of the ovaries.pptxAeyshaBegum
 
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classification
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classificationCa ovary staging(AJCC 8th Edition& FIGO 2014) and classification
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classificationDr.Bhavin Vadodariya
 
Malignant ovarian tumors
Malignant ovarian tumorsMalignant ovarian tumors
Malignant ovarian tumorsrajeev sood
 
Pelvic mass of ovarian/adenexal origin
Pelvic mass of ovarian/adenexal originPelvic mass of ovarian/adenexal origin
Pelvic mass of ovarian/adenexal originEzmeer Emiral
 

Similar to Ovaries and Ovarian Tumours (20)

Benign ovarian tumours
Benign ovarian tumoursBenign ovarian tumours
Benign ovarian tumours
 
benignovariantumours-121018102005-phpapp02.pdf
benignovariantumours-121018102005-phpapp02.pdfbenignovariantumours-121018102005-phpapp02.pdf
benignovariantumours-121018102005-phpapp02.pdf
 
Benign ovarian masses
Benign ovarian masses Benign ovarian masses
Benign ovarian masses
 
Benign ovarian Neoplasms Dr.H.K.Cheema-Professor-OBG.PIMS,Jalandhar
Benign ovarian Neoplasms   Dr.H.K.Cheema-Professor-OBG.PIMS,JalandharBenign ovarian Neoplasms   Dr.H.K.Cheema-Professor-OBG.PIMS,Jalandhar
Benign ovarian Neoplasms Dr.H.K.Cheema-Professor-OBG.PIMS,Jalandhar
 
Ovarian tumors
Ovarian tumorsOvarian tumors
Ovarian tumors
 
Lect 3- overy cancer
Lect 3- overy cancerLect 3- overy cancer
Lect 3- overy cancer
 
Ovarian Malignant PPT.pptx
Ovarian Malignant PPT.pptxOvarian Malignant PPT.pptx
Ovarian Malignant PPT.pptx
 
Ovarian Malignant.pptx
Ovarian Malignant.pptxOvarian Malignant.pptx
Ovarian Malignant.pptx
 
Ovarian Malignant.pptx
Ovarian Malignant.pptxOvarian Malignant.pptx
Ovarian Malignant.pptx
 
Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)
Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)
Gynecology 5th year, 5th & 6th lectures (Dr. Sallama Kamil)
 
Benign lesions of the ovaries.pptx
Benign lesions of the ovaries.pptxBenign lesions of the ovaries.pptx
Benign lesions of the ovaries.pptx
 
Germ cell tumor ovary.pptx
Germ cell tumor ovary.pptxGerm cell tumor ovary.pptx
Germ cell tumor ovary.pptx
 
Post Menopausal Bleeding
Post Menopausal BleedingPost Menopausal Bleeding
Post Menopausal Bleeding
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Endometrium part 1 2018
Endometrium part 1 2018Endometrium part 1 2018
Endometrium part 1 2018
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Ovaries
OvariesOvaries
Ovaries
 
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classification
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classificationCa ovary staging(AJCC 8th Edition& FIGO 2014) and classification
Ca ovary staging(AJCC 8th Edition& FIGO 2014) and classification
 
Malignant ovarian tumors
Malignant ovarian tumorsMalignant ovarian tumors
Malignant ovarian tumors
 
Pelvic mass of ovarian/adenexal origin
Pelvic mass of ovarian/adenexal originPelvic mass of ovarian/adenexal origin
Pelvic mass of ovarian/adenexal origin
 

More from Mujeeb M

Epidemiological Exercises: Q1 to Q10
Epidemiological Exercises: Q1 to Q10Epidemiological Exercises: Q1 to Q10
Epidemiological Exercises: Q1 to Q10Mujeeb M
 
Epidemiology Exercises
Epidemiology ExercisesEpidemiology Exercises
Epidemiology ExercisesMujeeb M
 
Ophthalmic Lenses
Ophthalmic LensesOphthalmic Lenses
Ophthalmic LensesMujeeb M
 
Chronic Dacryocystitis
Chronic DacryocystitisChronic Dacryocystitis
Chronic DacryocystitisMujeeb M
 
Pseudophakia
PseudophakiaPseudophakia
PseudophakiaMujeeb M
 
Lid Swellings
Lid SwellingsLid Swellings
Lid SwellingsMujeeb M
 
Uterine Corpus Tumours
Uterine Corpus TumoursUterine Corpus Tumours
Uterine Corpus TumoursMujeeb M
 
Uterine Corpus
Uterine CorpusUterine Corpus
Uterine CorpusMujeeb M
 

More from Mujeeb M (13)

Epidemiological Exercises: Q1 to Q10
Epidemiological Exercises: Q1 to Q10Epidemiological Exercises: Q1 to Q10
Epidemiological Exercises: Q1 to Q10
 
Epidemiology Exercises
Epidemiology ExercisesEpidemiology Exercises
Epidemiology Exercises
 
Ophthalmic Lenses
Ophthalmic LensesOphthalmic Lenses
Ophthalmic Lenses
 
Chronic Dacryocystitis
Chronic DacryocystitisChronic Dacryocystitis
Chronic Dacryocystitis
 
Cataract
CataractCataract
Cataract
 
Aphakia
AphakiaAphakia
Aphakia
 
Pterygium
PterygiumPterygium
Pterygium
 
Pseudophakia
PseudophakiaPseudophakia
Pseudophakia
 
Lid Swellings
Lid SwellingsLid Swellings
Lid Swellings
 
Cervix
CervixCervix
Cervix
 
Breast
BreastBreast
Breast
 
Uterine Corpus Tumours
Uterine Corpus TumoursUterine Corpus Tumours
Uterine Corpus Tumours
 
Uterine Corpus
Uterine CorpusUterine Corpus
Uterine Corpus
 

Recently uploaded

Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...saminamagar
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 

Recently uploaded (20)

Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 

Ovaries and Ovarian Tumours

  • 1. Dr. Saumya, Dept of Pathology, SIMS www.shadan.in
  • 2. NORMAL OVARIES  Normal size 5 x 3 x 3cm  Variation in dimensions can result from  Endogenous hormonal production(varies with age and menstrual cycle)  Exogenous substances, including OCs, GnRH agonists, or ovulation-inducing medication, may affect size
  • 3.
  • 4. Lifetime Risk of ovarian neoplasm  A woman has 5–10% lifetime risk of undergoing surgery for a suspected ovarian neoplasm and  13–21% of these will be found to be have an ovarian malignancy
  • 5.  Differential diagnosis of the adnexal masses varies considerably with the age of the patients.  In pre-menarchal girls and post-menopausal women adnexal mass should be considered highly abnormal – requires immediate investigation.  In menstruating patients differential diagnosis is varied.
  • 6. Clinical features: 1. Pelvic pain 2. Menstrual irregularities ( abnormal pattern of ovarian hormone secretion). 3. Infertility; failure of ovulation (Stein-Leventhal). 4. Ovarian mass : either non-neoplastic (cysts) or neoplastic (cystic or solid).
  • 7. DIAGNOSTIC EVALUATION OF THE PATIENT WITH AN ADNEXAL MASS  Complete physical examination  Pelvic ultrasound examination  Computed tomography scan with contrast enhancement or intravenous pyelography  Colonoscopy or barium enema study, if symptomatic  Laparoscopy, laparotomy
  • 8. OVARIAN MASSES FUNCTIONAL INFLAMMATORY NEOPLASTIC OTHERS FOLLICULAR CYST CORPUS LUTEUM CYST THECA LUTEIN TUBO OVARIAN ABSCESS BENIGN BORDERLINE MALIGNANT ENDOMETRIOMA ENLARGED PCO PAROVARIAN CYST
  • 9. COMMON OVARIAN TUMOURS Infancy Pre pubertal Adolescent Reproductive Peri Menopausal Post Menopausal 1 Functional cyst Functional cyst Functional cyst Functional cyst Epithelial ovarian tumor Neoplastic ovarian tumor 2. Germ cell tumor Germ cell tumor Germ cell tumor Dermoid Functional cyst Functional cyst 3. Epithelial tumor Epithelial tumor Mets
  • 10. Functional ovarian cysts  Follicular cysts  Corpus luteum cysts  Theca lutein cysts  Luteomas of pregnancy By far the most common clinically detectable enlargements of the ovary in the reproductive years. All are benign and usually asymptomatic.
  • 11. Follicular cysts  Cystic follicle is defined as Follicular cyst of diameter > 3cm  Most common functional cysts.  Rarely larger than 8cm.  Lined by granulosa cells  Found incidentally on pelvic examination  Usually resolve within 4 – 8 weeks with expectant management  May rupture or torse occasionally causing pain and peritoneal symptoms.
  • 13.
  • 14.
  • 15. Corpus luteal cyst  Less common than follicular cyst.  May rupture leading to hemoperitoneum and requiring surgical management( more in patients taking anti coagulants or with bleeding diathesis)  Unruptured cysts may cause pain because of bleeding into enclosed ovarian cyst cavity.
  • 17.
  • 18.
  • 19. Theca lutein cysts  Least common  Usually bilateral  Result from overstimulation of the ovary by β- hCG  Do not commonly occur in normal pregnancy  Often associated with hydatidiform moles, choriocarcinoma, multiple gestations, use of clomiphene and GnRH analogues.  May be quite large (up to 30 cm) , multicystic, and regress spontaneously.
  • 21. Polycystic ovarian (Stein-Leventhal syndrome(PCOD)  It is important cause of infertility. There is excessive production of androgens, increase conversion of androgens to estrogen, insulin resistance, and inappropriate gonadotrophin production by the pituitary.  Morphology: Ovaries are large, white, many subcortical follicular cysts(0.5-1 cm.) in diameter, and covered by thickened fibrosed outer tunica. No corpora lutea (= no ovulation).  Manifestations: Young females with Oligomenorrhea, infertility, obesity & hirsuitism.
  • 23. Endometriosis (chocolate cyst)  Most common site of involvement is the ovary.  Endometriomas are pseudocysts formed by invagination of the ovarian cortex, sealed off by adhesions.  They may completely replace normal ovarian tissue. Cyst walls are usually thick and fibrotic.  USG: anechoic cysts to cysts with diffuse low-level echoes to solid- appearing masses. Fluid–fluid or debris–fluid levels may also be seen. They may be unilocular or multilocular with thin or thick septations  Malignant transformation: 0.3% to 0.8%  Management: medical and/ or surgical
  • 24.
  • 25.
  • 26. Management of functional cysts  Expectant  Watchful waiting for two or three cycles is appropriate.  Combined oral contraceptives appear to be of no benefit.  Should cysts persist, surgical management is often indicated. Oral contraceptives for functional ovarian cysts (Review) Cochrane Database of Systematic Reviews 2011
  • 27.
  • 28. OVARIAN TUMORS - Common forms of neoplasia in women. - 80-90% of ovarian tumors are benign. - Most ovarian tumors occur between 20-45 years. - Ovarian cancer is second MC malignancy of the female genital tract (after endometrial cancer). - Most ovarian tumors are derived from surface epithelium, and “CA-125” is the tumor marker for surface epithelial tumors of the ovary. - Malignant ovarian tumors present at a late stage, thus are associated with high mortality rate. - Known risk factors are nulliparity, family history, and specific inherited mutations (BRCAI & BRCAII) genes.
  • 29. Precursor Ovarian component Other female genital tract structures Coelomic epithelium Ectopic endometrial epithelium—Mullerian Epithelium Surface epithelium 1.Fallopian tubes( ciliated columnar serous cells) 2.Endometrial lining(non ciliated columnar cells) 3. Endocervical glands (mucinous non ciliated) Yolk Sac Germ cells(toti potent) Sex cords Stroma of the ovary Endocrine apparatus of post natal ovary.
  • 30.
  • 31. Tumour types-- a basic classification Site of origin Types Frequency Age group Surface epithelial tumours 1.Serous 2.Mucinous 3.Endometroid 4.Clear cell 5.Brenner 60%-70% 20 years and greater Germ cell 1.Teratoma 2.Dysgerminoma 3.Endodermal Sinus(Yolk Sac Tumour) 4.Choriocarcinoma 15%-20% 0 to 25 years and greater Sex cord stromal tumours 1.Granulosa Theca cell tumours 2.Sertoli-Leydig cell tumours 3.Gynandroblastoma 5%-10% All ages Miscellaneous 1.Lipid cell tumour 2.Gonadoblastoma Variable variable Metastasis Krukenberg tumours 5% variable
  • 32.
  • 33.
  • 34. III. SEX CORD-STROMAL TUMORS: 1- Granulosa-Theca cell tumor: secrete estrogen 2- Sertoli-Leydig cell tumor: secrete androgens 3- Fibroma: associated with Meig’s syndrome 4- Sex cord stromal tumor with annual tubules 5- Gynandroblastoma 6- Steroid (Lipid)cell tumors
  • 35.
  • 36. I. Surface mullerian epithelial tumors: (Benign, Borderline, and Malignant) 1-Serous tumors: composed of ciliated columnar (tubal type) epithelium 2- Mucinous tumors: composed of mucus-secreting (cervical canal type) epithelium 3- Endometrioid tumors: composed of glandular (endometrium-like) epithelium. 4- Brenner’s tumors: composed of transitional (urothelium-like) epithelium 5- Clear cell tumors.
  • 37. Serous tumors Cysts are lined by tall columnar, ciliated epithelial cells (fallopian tube type) & filled with serous fluid. Types:  Benign Serous Tumors (Cystadenomas): (60%), smooth lining & no papillary or solid areas. 20% are bilateral.  Borderline Serous Tumors (low malignant potential): (15%), epithelial atypia, solid areas, but no stromal invasion. 30% are bilateral.  Malignant Serous Tumors (Cystadenocarcinomas): (25%) multilayered epithelium, solid areas & papillary structures invasing the stroma. 65% are bilateral. The prognosis depends on stage, and the presence of peritoneal implants means poor prognosis.
  • 38. Serous cystadenomas  Benign tumors typically have a smooth glistening cyst wall with no epithelial thickening or with small papillary projections.  Microscopy : the cysts are lined by columnar epithelium, which has abundant cilia in benign tumors. Microscopic papillae may be found
  • 39.
  • 40.
  • 41.
  • 42. Borderline serous tumours  Borderline tumors contain an increased number of papillary projections  Exhibit increased complexity of the stromal papillae – hierarchical pattern, stratification of the epithelium and mild nuclear atypia, but invasion of the stroma is not seen or there is stromal microinvasion (< 1cm).
  • 45. Serous carcinoma  Serous carcinoma are classified into 2 subtype  low-grade serous carcinoma (LGSC)  High-grade serous carcinoma(HGSC)  These tumors are different based on their molecular study.
  • 47. APST - Atypical proliferative serous tumour SBT – Serous borderline tumour
  • 48. Spread of STIC from the Fimbria to the Ovarian Surface
  • 49. Development of Cortical Inclusion Cyst from Tubal Epithelium
  • 50.
  • 51.
  • 52.
  • 53. HGSC • Most common ovarian carcinomas. • High stage disease at the time of presentation. • Histopathology: – Highly stratified epithelium with a fenestrated appearance and slit-like spaces, with/without solid or microcystic growth. – The tumor cells are of intermediate size, with scattered bizarre mononuclear giant cells, prominent nucleoli, and high mitotic rate. – >3 fold variation in nuclear size, and mitosis >12/10HPF distinguishes HGSC from LGSC.
  • 54.
  • 55.
  • 56.
  • 57.
  • 58.
  • 59.
  • 60.
  • 61. LGSC • Uncommon tumor(<5%) with excellent prognosis due to its indolent course and delayed recurrence. • Histopathology: – Uniform nuclei and differentiated architecture with papillary growth; – Numerous psammoma bodies. – The uniformity of the nuclei with <3 fold variation, is the principal criterion for distinguishing between LGSC and HGSC. – LGSC is considered microinvasive if invasive foci measures <10mm2.
  • 62. • Molecular genetics: – BRAF mutation – KRAS mutation – Unlike HGSC, no BRCA germline mutation, no chromosomal instability. • Therapy: – Surgical excision. – Unlike HGSC, it is Less sensitive for platinum based chemotherapy.
  • 63. Low grade ovarian serous carcinoma with a micropapillary pattern Transition between borderline serous cystadenoma and invasive low grade serous carcinoma.
  • 64.
  • 65.
  • 66.
  • 67.
  • 68.
  • 69. Mucinous carcinoma  Arise from transitional epithelial nests in paraovarian locations at the tubo-peritoneal junction.  Histopathology:  Heterogeneous group of tumors.  Benign-appearing, borderline, intraepithelial carcinoma, and invasive patterns may coexist within an individual neoplasm  Mucinous borderline tumor with intraepithelial carcinoma is used for those tumors that lack the architectural features of carcinoma but show cytological features of malignancy.
  • 70. Large cystic masses, huge size, unilateral and multiloculated. Cysts filled with sticky gelatinous fluid. They either lined by tall columnar mucus-secreting (rich in glycoprotein) epithelium (intestinal-type mucinous cystomas) or show papillary architectures and focal cilia (mullerian mucinous tumors), which may be associated with endometriosis. 1- Benign Mucinous Tumors (cystadenomas): 80%; large cysts with smooth lining & no atypia. 5% are bilateral. 2- Borderline Mucinous Tumors (of low malignant potential): 10-15%; cellular atypia, but no stromal invasion. 3- Malignant Mucinous Tumors (Cystadenocarcinomas): 5-10%; atypia, solid sheets & stromal invasion. 20% bilateral. Seeding in the peritoneum with malignant deposits causes pseudomyxoma peritonei. Usually mucinous cystadenocarcinomas are of intestinal type.
  • 71.  Pseudomyxoma peritonei is marked by extensive mucinous ascites, cystic epithelial implants on the peritoneal surfaces, adhesions, and frequent involvement of the ovaries.  Pseudomyxoma peritonei, if extensive, may result in intestinal obstruction and death
  • 72.
  • 73.
  • 74.
  • 78.
  • 79.
  • 80.
  • 81.
  • 82. • 20% of all ovarian tumours. • Majority are carcinomas, if benign forms are present they are cyst adenofibromas. • Distinguished from serous and mucinous tumours by presence of tubular glands bearing close resemblance to benign or malignant endometrial glands. • 30% associated with carcinoma endometrium and 15% with endometriosis whereas 40% involve both ovaries. Endometriod carcinoma
  • 83.  Gross: presence of both solid and cystic areas  Microscopic: Tubular glands resemble those of typical endometrial adenocarcinoma.
  • 84. Clear cell tumour  These are uncommon and aggressive tumours.  Grossly can present in solid and or cystic pattern (solid tumour with cysts and necrosis)  Microscopically: large epithelial cells with abundant clear cytoplasm.
  • 85.
  • 86. Brenner tumour  Uncommon adenofibromas  Epithelial components– nests of transitional cells resembling urinary bladder.  Most are benign,variable size(1cm to 30 cm).  Gross—solid or cystic  Microscopic – fibrous stroma resembling normal ovarian stroma seperated by sharply demarcated nests of urinary tract, with mucinous glands.
  • 87. Brenner tumour  Gross:A sharply demarcated, yellow-white fibromatous tumor occupies a portion of the sectioned surface of the ovary. Microscopically:Nests of transitional cells, some containing cysts, lie in a fibromatous stroma.
  • 88. II. GERM CELL TUMORS: 1- Teratoma 2- Dysgerminoma (seminoma ovarii) 3- Yolk sac tumor= Endodermal sinus tumor 4- Embryonal carcinoma (MC mixed with other types) 5- Choriocarcinoma (MC mixed with other types)
  • 89. Germ cell tumors 15-20% of all ovarian tumors. It arises from totipotent germ cells capable of differentiation into the three germ layers. - Mostly benign cystic teratomas while Other tumours are found principally in children and young adults. - Homologous to germ cell tumours in male testis.
  • 92. Mature (Benign) Teratoma: MC germ cell tumors of the ovary, cystic (dermoid cysts), lined by skin & hairs, and filled with sebaceous secretion. There may be mature cartilage, bone (teeth) & other structures. 10-15% are bilateral. < 1% undergo malignant transformation (MC sq.c.c.). Immature (Malignant) Teratoma: Rare , solid, bulky, with areas of hemorrhage and necrosis. It contains embryonic elements of he three germ layers. Age: adolescent & young women. Grading is based on the amount of immature neuroepithelium. It causes wide spread extraovarian metatases depending on the degree of the immaturity of the including tissues. Monodermal (Specialized )Teratomas: differentiate along the line of single tissue. Examples:- Strauma ovarii is MC (mature thyroid tissue) – Carcinoid tumor.
  • 93. MATURE CYSTIC GROSS: unilocular cysts with hair and cheesy material. Thin walled gray white wrinkled epidermis.hair, tooth and calcification are found within walls. TERATOMA MICROSCOPIC: cyst wall stratified squamous epithelium and underlying sebaceous,sweat glands and other adnexa.other structures like thyroid tissue,cartilage bone may be seen.
  • 94.
  • 95.
  • 96.
  • 97.
  • 98. Dysgerminoma The ovarian counterpart of testicular seminoma.  Gross- Yellowish white to gray pink solid, fleshy tumors, of children & young adults. 10% are bilateral.  Microscopy: sheets of large cells, separated by fibrous stroma infiltrated by small lymphocytes. Non-functional, but may be mixed with other germ cell elements that produce hCG  Malignant, but radiosensitive & chemosensitive, with relative good prognosis if treated early.
  • 99.  GROSS: Small nodules to very large size.Cut surface: yellow white to gray pink appearance and are soft and fleshy.  Microscopic:large vesicular cells, clear cytoplasm and well defined boundaries and centrally placed regular nuclei.cells in sheets or cords seperated by scant fibrous stroma, which has mature lymphocytes.
  • 100.
  • 101.
  • 102. Endodermal Sinus Tumor ( Yolk Sac Tumor)= Infantile embryonal carcinoma It arises from mutlipotent embryonal carcinoma cells differentiating towards yolk sac structures. - Affects children & adolescents; grows rapidly & spreads widely, but is radio- & chemosensitive. - Histologically: it shows cystic spaces into which papillary structures with central blood vessels, the cyst spaces and papillary structures are lined by immature epithelium giving glomeruloid or “Schiller-Duval” bodies; There are intracellular and extracellular hyaline droplet (characteristic feature). Tumor cells are positive for Alpha-fetoprotein (tumor marker).
  • 104. Choriocacinoma It is due to teratogenous development of germ cells. Most cases exist in combination with other germ cell tumors. - Resembles gestational choriocarcinoma, highly malignant, spreads widely & elaborates hCG (tumor marker). - Microscopic picture: malignat syncitiotrophoblasts & cytotrophoblasts in a hemorrhagic stroma. Gonadal choriocarcinomas are more resistant to chemotherapy than Gestational choriocarcinomas.
  • 105. III. SEX CORD-STROMAL TUMORS:  1- Granulosa-Theca cell tumor: secrete estrogen  2- Sertoli-Leydig cell tumor: secrete androgens  3- Fibroma: associated with Meig’s syndrome  4- Sex cord stromal tumor with annual tubules  5- Gynandroblastoma  6- Steroid (Lipid)cell tumors
  • 106. Granulosa - theca cell tumor  1- 5% of all ovarian tumors, of peri & post-menopausal women. - Usually unilateral, solid white yellow, consisting of theca cells & granulosa cells, arranged in “Call-Exner” rosettes. - Elaborated large amount of estrogen & may cause precocious sexual development in children, endometrial hyperplasia, cystic changes of the breast or endometrial carcinoma (estrogen effects). - Pure granulosa cell tumors are potentially malignant, clinical malignancy occurs in 5-25% of cases, but they are slowly growing & 10-years survival is above 85%. - Pure Theca cell Tumors - THECOMA
  • 107.  Gross: small partly solid, partly cystic and mostly unilateral.The neoplasm composed of yellow-white tissue with hemorrhage, some of which is intracystic
  • 108.  Microscopically: granulosa cell arranged in various patterns like micro,macro follicular, trabecular,bands and sheets.CALL-EXNER BODIES characterstic rosette like structures having central rounded pink mass surrounded by granulosa
  • 109.
  • 110.
  • 111.  Pure thecoma are almost always benign.  Occur in post menopausal women.  Oestrogen dominant tumours– endometrial disorders , carcinoma and cystic disease of breast.  If androgen secreting – virilizing effects. Thecoma
  • 112.  Gross: a solid firm mass upto 10 cm in diameter.Section shows. solid, lobulated, yellow tissue.
  • 113.  Microscopically : spindle shaped theca cells along with variable amount of hyalinized collagen, cytoplasm of these cells is vacuolated and lipid laden.
  • 114. SERTOLI-LEYDIG CELL TUMORS (Androblastoma= Arrhenoblastoma= Hilus Cell Tumors = Gonadoblastomas)  Androgen producing neoplasm (rarely produce estrogen)  Recapitulate the testicular counterpart & produce masculinization or defemenization (Androgen) effect.  Usually unilateral & benign.  Gross: cut surface is solid and colour gray to golden brown.  Microscopic picture: Tubules lined with Sertoli cells and Leydig cells interspersed in the stroma. Gynandroblastoma: Extremely rare. It consists of a mixture of granulosa/theca & sertoli/ leydig cells. It may be benign or malignant.
  • 115. Sertoli Leydig Cell Tumor-Ovary
  • 116.  Common ovarian tumours. Usually bilateral  Hormonally inactive  Meig’s syndrome: fibroma with pleural effusion and benign ascites.  Gross large firm fibrous usually bi-lateral mass.  Microscopic composed of spindle shaped well differentiated fibroblasts and collagen.  Fibrothecoma: combination of fibroma and thecoma. Fibroma
  • 117.
  • 118. Krukenberg tumor Metastatic tumors • Very common, • The primary tumors is from abdominal and breast tumors.  A bilateral metastatic ovarian carcinoma, composed of mucin- producing signet ring cells, metastasizing from GIT, mostly from the stomach, it may produce pseudomyxoma peritonei like well differentiated appendicial tumors.

Editor's Notes

  1. If ovulation does not occur, a clear fluid filled follicular cyst lined by granulosa cell may result.
  2. Notice the smooth inner lining of this cyst, which is nothing more than a follicle which has gotten large but neither burst nor undergone atresia
  3. When ovulation occurs , corpus luteum is formed that may become abnormally enlarged through internal hemorrhage or cyst formation Variable delay in onset of menses and confusion regarding possibility of ectopic pregnancy: acute abdomen
  4. Ovary with hemorrhagic corpus luteum cyst Hemorrhagic corpus luteum with spider web like contents Hemorrhagic cyst with blood clot. Hemorrhagic cyst with unusual appearance simulating a neoplasm.
  5. Sonogram from a patient with bilateral theca lutein cysts. The typical multilocular appearance is noted in the left ovary.
  6. Ovarian Endometriomas demonstrating hypoechoic cystic structures with low amplitude uniformly distributed echotexture in the cavity of the cyst.